Pdf | Clsi M22a3
Mycobacteria, such as Mycobacterium tuberculosis, are notorious for their slow growth rates and resistance to many antimicrobial agents. Nocardioform bacteria, like Nocardia asteroides, are commonly found in soil and can cause infections in humans, particularly in immunocompromised individuals. Other actinomycetes, such as Streptomyces and Actinomadura, are also known to cause infections in humans.
Maintain rigorous Quality Assurance (QA) programs (such as ISO 13485 certification).
To qualify their products for "exempt" status in the laboratory, manufacturers must:
The document cites other essential CLSI standards (e.g., M29 for biosafety) and international documents like ISO 11133:2014 – “Microbiology of food, animal feed and water – Preparation, production, storage and performance testing of culture media.”
To qualify for the exemptions allowed under M22-A3, the commercial manufacturer must adhere to strict guidelines: clsi m22a3 pdf
The document contains comprehensive quality assurance (QA) procedures for both and users of prepared, ready‑to‑use microbiological culture media. It applies to all commercial culture media, regardless of packaging (plates, tubes, or other designs), and its recommendations are based on data collected through surveys of clinical laboratories by the College of American Pathologists (CAP).
The M22-A3 is the third edition, replacing the earlier M22-A2 standard published in 1996. It is developed through the CLSI consensus process, ensuring it reflects current best practices and scientific consensus. Key Features and Updates in M22-A3
Media used for susceptibility testing (e.g., Mueller-Hinton Agar, though this is also heavily governed by CLSI M100) Responsibilities Mandated by CLSI M22-A3
Retention times for QC records (typically 2+ years), error logs, corrective action forms, and lot number tracking. Maintain rigorous Quality Assurance (QA) programs (such as
Test with appropriate ATCC control organisms to verify growth, inhibition, and biochemical reactions. Why Laboratories Search for the CLSI M22-A3 PDF
: Using specific "ATCC" (American Type Culture Collection) control strains to confirm the media supports expected growth.
: Provides updated recommendations for QC of media used for difficult-to-grow organisms. Protocol Simplification
CLSI M22-A3 is the third edition of the approved standard developed by the Clinical and Laboratory Standards Institute to streamline and optimize quality control protocols for commercially manufactured culture media. The M22-A3 is the third edition, replacing the
The CLSI M22-A3 guideline provides detailed recommendations for susceptibility testing of mycobacteria, nocardioform, and other actinomycetes. Some key recommendations include:
The standard is divided into several sections that address:
The CLSI M22-A3 document is available for purchase on the CLSI website ( www.clsi.org ). You can also search for the document on various online libraries or academic databases. However, I couldn't find a freely available PDF version of the document.
Selective media for Neisseria gonorrhoeae (e.g., Thayer-Martin Agar) Manufacturer Responsibilities Under M22-A3